Prefilled Syringes Market Size
| Study Period | 2019 - 2029 |
| Market Size (2024) | USD 8.74 Billion |
| Market Size (2029) | USD 14.81 Billion |
| CAGR (2024 - 2029) | 11.11 % |
| Fastest Growing Market | Asia Pacific |
| Largest Market | North America |
| Market Concentration | Low |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Prefilled Syringes Market Analysis
The Prefilled Syringes Market size is estimated at USD 8.74 billion in 2024, and is expected to reach USD 14.81 billion by 2029, growing at a CAGR of 11.11% during the forecast period (2024-2029).
The COVID-19 pandemic had a positive impact on the global prefilled syringes market outlook, owing to the potential use of these syringes for COVID-19 vaccines. COVID-19 spurred the development of prefilled syringes, especially for low-temperature storage. For instance, in September 2021, Becton, Dickinson, and Company (BD) unlocked a new COVID-19 vaccination opportunity by displaying the suitability of its glass prefilled syringes for use with mRNA COVID-19 vaccine shots that need storing at ultralow temperatures. The company said that switching from vials to prefilled syringes can address the cost and complexity of vaccine administration. As a result, due to the outbreak of the COVID-19 pandemic in 2020, sales of prefilled syringes increased globally.
Growing demand for efficient and easy-to-use drug delivery devices and increasing efforts of healthcare professionals to reduce hospital errors are the principal factors driving the market growth. The fast-paced development of feature-rich devices with underlying technological advancements that make self-injecting safer and more convenient for patients, along with the impact of COVID-19, are expected to fuel the injectable drug delivery market during the forecast period.
Prefilled syringes have emerged as one of the fastest-growing choices for unit-dose medication as the pharmaceutical industry seeks new and more convenient drug delivery systems. For instance, the World Health Organization, in its article on self-care interventions published in June 2022, specified that the use of self-injectable contraception can help in the reduction of unintended pregnancies. Also, the article estimated that in a year, an individual spends less than 1 hour with a healthcare professional, whereas over 8,700 hours are spent on self-care. The increasing adoption of self-care among the public is expected to increase the demand for prefilled syringes, thereby boosting prefilled syringes market trends over the forecast period.
Additionally, increasing prevalence of diabetes and rheumatoid arthritis, and escalating adoption of biosimilars in developed regions are some other factors that will fuel the market expansion. According to the report published by SingleCare in January 2022, more than 14.0 million people suffer from rheumatoid arthritis globally every year. It also reported that rheumatoid arthritis affects more than 1.36 million adults in the United States annually. Additionally, as per the journal published by the American College of Rheumatology in July 2022, rheumatoid arthritis is the most common form of autoimmune arthritis in the United States. It also stated that around 0.6% to 1.0% of the population of the United States suffers from rheumatoid arthritis every year. As prefilled syringes provide safety without the added price, the usage of the same is expected to increase in the future.
Along with the aforementioned factors, a growing number of new product launches is predicted to actively contribute to industry expansion. For instance, in May 2022, Terumo Corporation launched a pre-fillable polymer syringe for low-dose applications, offering a safe, easy-to-use, and effective treatment option. Increasing government investments in cutting-edge syringe production will drive prefilled syringe manufacturers growth in the near future. For instance, in March 2022, the investment of USD 84.53 million in Hungary is intended to address the expanding global demand for pre-fillable glass syringes. The expansion is set to be complete by 2024 and is expected to support the demand for the product in the near future.
However, product recalls and the availability of alternate drug delivery methods are the factors expected to restrain the market growth.
Prefilled Syringes Market Trends
Diabetes Segment is Holds Significant Market Share and Expected to do the Same Over the Forecast Period
Diabetes is a chronic disease that occurs when the pancreas can no longer make insulin or when the body cannot make good use of the insulin it produces. People with diabetes widely use prefilled syringes to administer multiple doses of insulin daily. A large patient base, a growing prevalence of diabetes, and the need for effective and safer insulin delivery devices are some of the factors expected to help maintain the dominance of this segment throughout the forecast period.
The rising prevalence of diabetes around the world is a primary factor driving prefilled syringe market expansion. Diabetes is one of the world's most serious public health problems, posing a significant threat to public health and socioeconomic development. For instance, according to the International Diabetes Federation (IDF), in 2021, around 537 million adults between 20 years and 79 years of age were living with diabetes. As per the same source, the number of people living with diabetes is projected to increase to 63 million by 2030 and 783 million by 2045.
Moreover, major companies such as BD are producing prefilled syringes designed exclusively for chronic disease therapy in order to increase their market position. For instance, in May 2021, BD announced plans to spin out its Diabetes Care division as a separate, publicly traded company ("NewCo"). BD Diabetes Care has been a major force behind the adoption of insulin syringes and other products, generating roughly 8 billion injection devices each year and supporting approximately 30 million patients. Over the foreseeable term, such factors are expected to drive the product demand.
Additionally, in March 2022, Novo Nordisk made its smart insulin pens available in the UK, giving people treated within the NHS for diabetes access to devices that can monitor and record dosing information for the first time. Similarly, in November 2020, Medtronic PLC launched InPen integrated with real-time Guardian Connect CGM data. InPen is the first and only FDA-cleared smart syringe on the market for people on multiple daily injections (MDI). Therefore, the above-mentioned factors are expected to drive segmental growth in the smart syringe market during the forecast period.
North America Expected to Hold a Significant Market Share and Expected to do the Same in the Forecast Period
North America is expected to hold a significant market share in the studied market over the forecast period due to the high preference of healthcare practitioners for prefilled injectable devices in order to decrease needle-related injuries. Additionally, the region has a presence of major market players influencing the North America prefilled syringes market outlook, such as Gerresheimer AG, SCHOTT Group, Stevanato Group, Haselmeier AG, and Owen Mumford Ltd. These companies have strengthened their presence in the region over the years. Thus, the demand for prefilled syringes is increasing in the United States, fueling the studied market's growth.
According to the Pan American Health Organization report 2022, at least 62 million people live with diabetes in America, a number which is expected to be much higher given that around 40% of those with the disease are unaware they have the condition. In line with the current trends, the number of people with diabetes in the region is projected to reach 109 million by 2040. Patients with Type 1 diabetes undergo regular intra-venous administration of insulin to control their sugar levels. Owing to ease of administration, prefilled syringes can make self-administration more convenient and viable.
Moreover, innovative product launches and approvals in the United States are anticipated to fuel the market growth over the forecast period. For instance, in September 2022, BD (Becton, Dickinson, and Company) introduced a new product in the glass prefillable syringes market, the BD Effivax Glass PFS, which aims to set a new standard in performance for vaccine PFS. The new BD Effivax Glass PFS has been designed in collaboration with pharmaceutical companies to meet the complex and evolving needs of vaccine manufacturing.
Further, in October 2022, West Pharmaceutical Services, Inc., a global manufacturer of innovative solutions for injectable drug administration, participated in the 2022 Parenteral Drug Association (PDA) Universe of prefilled syringes and Injection Devices Conference and presented the development of large volume delivery systems, self-injection devices, and pre-fillable syringe component expertise. Thus, such developments in the country are expected to fuel market growth.
Thus, owing to the abovementioned factors, the studied market in the North American region is expected to witness promising growth over the forecast period.
Prefilled Syringes Industry Overview
The prefilled syringes market is fragmented in nature due to the presence of several companies. These market participants are undertaking several organic and inorganic growth strategies to capture a higher revenue share in this industry. Some of the prominent prefilled syringe manufacturers functioning in the global prefilled syringes market include Becton, Dickinson, and Company, Terumo Corporation, Gerresheimer AG, SCHOTT, and West Pharmaceutical Services, Inc., among others.
Prefilled Syringes Market Leaders
-
Becton Dickinson and Company
-
West Pharmaceutical Services, Inc.
-
Gerresheimer AG
-
Terumo Corporation
-
SCHOTT AG
*Disclaimer: Major Players sorted in no particular order
Prefilled Syringes Market News
- In January 2022, Owen Mumford announced that it received approval for its UniSafe 1mL safety device for pre-filled syringes in Asia. In Europe, regulatory approval has also been granted for UniSafe 1mL, and the product is now available on the market as a combination product with a drug for the treatment of rheumatoid arthritis.
- In January 2021, Aurobindo Pharma Limited received approval from the United States Food and Drug Administration (USFDA) to manufacture and market Naloxone HCl Injection Prefilled Syringe 2 mg/2 mL.
Prefilled Syringes Market Report - Table of Contents
1. INTRODUCTION
1.1 Study Assumptions and Market Definition
1.2 Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Growing Adoption of Self-care Devices
4.2.2 Benefits Associated with Prefilled Syringes
4.3 Market Restraints
4.3.1 Product Recalls
4.3.2 Availability of Alternate Drug Delivery Methods
4.4 Porter's Five Forces Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5. MARKET SEGMENTATION (Market Size by Value - USD million)
5.1 By Material
5.1.1 Glass Prefilled Syringe
5.1.2 Plastic Prefilled Syringe
5.2 By Application
5.2.1 Diabetes
5.2.2 Anaphylaxis
5.2.3 Rheumatoid Arthritis
5.2.4 Oncology
5.2.5 Other Applications
5.3 By Type
5.3.1 With Needle
5.3.2 Without Needle
5.4 Geography
5.4.1 North America
5.4.1.1 United States
5.4.1.2 Canada
5.4.1.3 Mexico
5.4.2 Europe
5.4.2.1 Germany
5.4.2.2 United Kingdom
5.4.2.3 France
5.4.2.4 Italy
5.4.2.5 Spain
5.4.2.6 Rest of Europe
5.4.3 Asia-Pacific
5.4.3.1 China
5.4.3.2 Japan
5.4.3.3 India
5.4.3.4 Australia
5.4.3.5 South Korea
5.4.3.6 Rest of Asia-Pacific
5.4.4 Middle East & Africa
5.4.4.1 GCC
5.4.4.2 South Africa
5.4.4.3 Rest of Middle East & Africa
5.4.5 South America
5.4.5.1 Brazil
5.4.5.2 Argentina
5.4.5.3 Rest of South America
6. COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Becton, Dickinson and Company
6.1.2 Terumo Corporation
6.1.3 Gerresheimer AG
6.1.4 SCHOTT
6.1.5 West Pharmaceutical Services, Inc.
6.1.6 Stevanato Group S.p.A.
6.1.7 NIPRO
6.1.8 Plas-Tech Engineering, Inc.
6.1.9 Taisei Kako Co.,Ltd.
6.1.10 Laboratoire AGUETTANT (AGUETTANT LTD)
- *List Not Exhaustive
7. MARKET OPPORTUNITIES AND FUTURE TRENDS
Prefilled Syringes Industry Segmentation
As per the scope of this report, a prefilled syringe is a single dose packet of the parenteral drug, to which a needle has been fixed by the manufacturer. Prefilled syringes provide greater patient safety by reducing the potential for inadvertent needle sticks and exposure to toxic products that can occur while drawing medication from vials. The Prefilled Syringes Market is segmented By Material (Glass Prefilled Syringe and Plastic Prefilled Syringe), Application (Diabetes, Anaphylaxis, Rheumatoid Arthritis, Oncology, and Other Applications), Type (With Needle and Without Needle), and Geography (North America, Europe, Asia-Pacific, Middle East & Africa, and South America). The market report also covers the estimated market sizes and trends for 17 different countries across major regions globally. The report offers the value (in USD million) for the above segments.
| By Material | |
| Glass Prefilled Syringe | |
| Plastic Prefilled Syringe |
| By Application | |
| Diabetes | |
| Anaphylaxis | |
| Rheumatoid Arthritis | |
| Oncology | |
| Other Applications |
| By Type | |
| With Needle | |
| Without Needle |
| Geography | ||||||||
| ||||||||
| ||||||||
| ||||||||
| ||||||||
|
Prefilled Syringes Market Research FAQs
How big is the Prefilled Syringes Market?
The Prefilled Syringes Market size is expected to reach USD 8.74 billion in 2024 and grow at a CAGR of 11.11% to reach USD 14.81 billion by 2029.
What is the current Prefilled Syringes Market size?
In 2024, the Prefilled Syringes Market size is expected to reach USD 8.74 billion.
Who are the key players in Prefilled Syringes Market?
Becton Dickinson and Company, West Pharmaceutical Services, Inc. , Gerresheimer AG, Terumo Corporation and SCHOTT AG are the major companies operating in the Prefilled Syringes Market.
Which is the fastest growing region in Prefilled Syringes Market?
Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029).
Which region has the biggest share in Prefilled Syringes Market?
In 2024, the North America accounts for the largest market share in Prefilled Syringes Market.
What years does this Prefilled Syringes Market cover, and what was the market size in 2023?
In 2023, the Prefilled Syringes Market size was estimated at USD 7.87 billion. The report covers the Prefilled Syringes Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Prefilled Syringes Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029.
Prefilled Syringes Industry Report
The report on the Global Prefilled Syringes Market provides an in-depth market analysis, covering trends and manufacturers. The market is segmented by material, application, type, and geography, providing insights into the market size, market share, and market growth. The industry analysis includes a market forecast outlook and a historical overview. This comprehensive industry report offers valuable industry information, highlighting market leaders and market trends.
The report includes industry outlook, industry research, and industry statistics, providing a detailed market overview. The analysis covers market data, market segmentation, and market value, offering a thorough market review. Additionally, the report includes industry reports, industry sales, and industry size, providing a complete market prediction.
A sample of this industry analysis is available as a free report PDF download. The report also features research companies and report examples, ensuring a comprehensive understanding of the market. The market forecast and market outlook are crucial for understanding future market dynamics, while the market predictions offer insights into potential market developments. The industry trends and growth rate are essential for identifying key market drivers and opportunities.
Prefilled Syringes Market Report Snapshots
